Kaunitz A M
University of Florida Health Science Center, Jacksonville 32209.
Am J Obstet Gynecol. 1992 Oct;167(4 Pt 2):1171-6. doi: 10.1016/s0002-9378(12)90407-x.
The most recent statistical evidence confirms a protective effect of oral contraceptive use against ovarian and endometrial cancers. Studies of the association between oral contraceptive use and cervical cancer continue to be hampered by confounding factors; however, results suggest that the overall risk of invasive cervical neoplasia is not increased. Although the association between oral contraceptive use and breast cancer remains controversial, existing data strongly suggest that overall risk of breast cancer is not increased by the use of oral contraceptives. In most candidates for oral contraceptive use, the benefits greatly outweigh the risks.
最新的统计证据证实了口服避孕药对卵巢癌和子宫内膜癌具有预防作用。口服避孕药与宫颈癌之间关联的研究仍受到混杂因素的阻碍;然而,结果表明浸润性宫颈肿瘤的总体风险并未增加。尽管口服避孕药与乳腺癌之间的关联仍存在争议,但现有数据有力地表明,口服避孕药不会增加乳腺癌的总体风险。在大多数适合使用口服避孕药的人群中,其益处远大于风险。